H

O

HEINZLEF , Olivier

Last name: HEINZLEF

First name: Olivier

July 2018 (v1)

Journal article

Metadata-only

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

Tourbah, Ayman Gout, Olivier Vighetto, Alain

BACKGROUND: Chronic visual loss is a disabling feature in patients with multiple sclerosis (MS). It was recently shown that MD1003 (high-dose pharmaceutical-grade biotin or hdPB) may improve disability in patients with progressive MS.OBJECTIVE: The aim of this study was to evaluate whether MD1003 improves vision compared with placebo in MS...

Uploaded on: December 4, 2022